{"id":813,"date":"2011-09-01T12:00:00","date_gmt":"2011-09-01T10:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2011\/schmerztherapie-mit-opioiden"},"modified":"2022-03-17T14:12:11","modified_gmt":"2022-03-17T13:12:11","slug":"schmerztherapie-mit-opioiden","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2011\/schmerztherapie-mit-opioiden","title":{"rendered":"Schmerztherapie mit Opioiden"},"content":{"rendered":"<p>Zusammenfassung: Zur Behandlung starker akuter und chronischer Schmerzen sind Opioide ein unverzichtbarer Bestandteil. Opioide unterscheiden sich in ihrer analgetischen Potenz, Pharmakokinetik und in ihren Applikationsformen. Bei eingeschr\u00e4nkter Nieren- und\/oder Leberfunktion sollten solche Opioide gew\u00e4hlt werden, die weitgehend unabh\u00e4ngig von der Nieren- oder Leberfunktion abgebaut werden oder keine aktiven Metabolite haben, da es sonst zu erheblichen [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zusammenfassung: Zur Behandlung starker akuter und chronischer Schmerzen sind Opioide ein unverzichtbarer Bestandteil. Opioide unterscheiden sich in ihrer analgetischen Potenz, Pharmakokinetik und in ihren Applikationsformen. Bei eingeschr\u00e4nkter Nieren- und\/oder Leberfunktion sollten solche Opioide gew\u00e4hlt werden, die weitgehend unabh\u00e4ngig von der Nieren- oder Leberfunktion abgebaut werden oder keine aktiven Metabolite haben, da es sonst zu erheblichen [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1071,2142,2143,2144,910,1613,2148,2152,19,2150,2149,2151,2145,13,2146,16,2147,754,2137,753,2139,2140,2141,328,2133,2136,2135,2134,2138],"class_list":["post-813","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-antiemetika","tag-buprenorphin","tag-ddd","tag-durchbruchschmerzen","tag-fahrtuechtigkeit","tag-fentanyl","tag-hydromorphon","tag-laxanzien","tag-methadon","tag-morphin","tag-naloxon","tag-neuropathische-schmerzen","tag-obstipation","tag-opiate","tag-opioid-rotation","tag-opioide","tag-oxycodon","tag-schmerzen","tag-schmerzmittel","tag-schmerztherapie","tag-sucht","tag-tapentadol","tag-tilidin","tag-tramadol","tag-tumorschmerzen","tag-verstopfung","tag-who","tag-wido","tag-wissenschaftliches-institut-der-aok"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=813"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/813\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}